- Testing Types
- USP ⟨671⟩ Containers – Performance Testing
Terms and Conditions
Sample Submission Form
Overview
USP ⟨671⟩ establishes standardized procedures for evaluating the performance of pharmaceutical packaging systems in protecting drug products from environmental exposure. PLS Analytical performs USP ⟨671⟩ studies to help manufacturers assess whether packaging systems provide the moisture protection and environmental barrier performance required for their intended application.
PLS Analytical performs USP ⟨671⟩ testing to evaluate the moisture barrier performance of finished pharmaceutical packaging systems. Depending on the packaging configuration and dosage form, studies may include moisture vapor transmission, water vapor permeation, and other performance evaluations that support packaging qualification, stability programs, shelf-life assessments, and regulatory submissions.
The ability of a packaging system to protect against moisture ingress is critical for maintaining product quality, stability, and shelf life, particularly for moisture-sensitive formulations. Evaluating packaging performance early helps manufacturers reduce stability risks, optimize packaging selection, and maintain confidence in long-term product protection.
PLS Analytical delivers USP ⟨671⟩ testing aligned with compendial requirements, helping manufacturers generate scientifically defensible data for packaging qualification, stability studies, and regulatory submissions.
Testing Services
PLS Analytical performs USP ⟨671⟩ testing to support packaging qualification, stability programs, supplier evaluations, regulatory submissions, and lifecycle quality management activities.
Moisture Vapor Transmission Evaluation
Moisture Vapor Transmission Evaluation
Moisture vapor transmission evaluation assesses the ability of pharmaceutical packaging systems to resist moisture ingress under controlled environmental conditions. Scientifically robust data supports moisture barrier assessments, packaging qualification, moisture-sensitive products, and product protection studies.
Packaging Performance Characterization
Packaging Performance Characterization
Packaging performance characterization evaluates the protective capabilities of finished pharmaceutical packaging systems. Scientifically robust data supports packaging qualification, packaging change control, supplier evaluation, product protection assessments, and packaging selection.
Stability & Shelf-Life Support Studies
Stability & Shelf-Life Support Studies
Stability and shelf-life support studies evaluate the long-term protective performance of pharmaceutical packaging systems throughout product storage. Scientifically robust data supports stability programs, shelf-life justification, commercial packaging qualification, lifecycle management, and regulatory submissions.
Advantages
USP ⟨671⟩ testing provides critical evidence that pharmaceutical packaging systems can maintain the environmental conditions necessary to preserve product quality throughout storage and distribution.
Improved Product Stability Protection
Performance testing helps verify that packaging systems provide appropriate protection against moisture-related degradation and quality risks.
Better Packaging Selection Decisions
Objective performance data supports informed decisions regarding packaging materials, configurations, and qualification strategies.
Reduced Stability and Compliance Risk
Early identification of packaging performance limitations helps prevent shelf-life challenges, stability failures, and regulatory concerns later in development.
